Lymphoma | What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma

Research To Practice | Oncology Videos · Jan 16, 2025 · 2h

Featuring perspectives from Dr Jeremy S Abramson, Dr Jennifer Crombie, Prof Martin Hutchings, Dr Matthew Lunning and Dr Tycel Phillips, moderated by Dr Abramson, including the following topics:

Introduction (0:00)

Chimeric Antigen Receptor (CAR) T-Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Abramson (2:17)

Bispecific Antibody Therapy for DLBCL — Prof Hutchings (28:51)

CAR T-Cell Therapy for Other Lymphoma Subtypes — Dr Lunning (52:01)

Bispecific Antibody Therapy for Follicular Lymphoma and Other Lymphoma Subtypes — Dr Phillips (1:17:46)

Tolerability Considerations with CAR…